|Articles|September 10, 2014
PRA Health Sciences Files for Initial Public Offering
PRA Health Sciences announced that it has filed a registration statement with the US Securities and Exchange Commission
Advertisement
PRA Health Sciences announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to a proposed initial public offering (“IPO”) of shares of its common stock by PRA Health Sciences. The number of shares to be offered and the price range has not yet been determined.
Read the full release here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV PatientsSeptember 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG ResearchSeptember 12th 2025
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug TrialsSeptember 11th 2025
Advertisement
Advertisement




.png)



.png)



.png)
.png)
